Loading…

Loading grant details…

Active NON-SBIR/STTR RPGS NIH (US)

Stem Cell-based Modeling of Placental Defects associated with Early-Onset Preeclampsia

$6.17M USD

Funder EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT
Recipient Organization University of California, San Diego
Country United States
Start Date Jul 01, 2024
End Date Apr 30, 2029
Duration 1,764 days
Number of Grantees 1
Roles Principal Investigator
Data Source NIH (US)
Grant ID 10858736
Grant Description

Project Summary/Abstract Preeclampsia (PE) is a multifactorial pregnancy syndrome that affects up to 10% of pregnancies worldwide, and is defined by new onset of hypertension and proteinuria or end-organ dysfunction appearing after 20 weeks of gestation. Although the well-accepted underlying pathophysiology of this disease involves both

maternal and fetal/placental factors, the symptoms resolve following the delivery of the placenta pointing to the importance of placental involvement in this disease. The placental histological phenotype of PE is known to have a wide range of lesions. Maternal vascular malperfusion (MVM), one of the predominant placental

injuries associated with PE, is known for abnormal syncytiotrophoblast and extravillous trophoblast differentiation and function, with some cases overlapping with fetal vascular malperfusion (FVM). However, the detailed underlying molecular and cellular pathophysiology associated with PE placenta showing MVM,

with or without FVM, is not well-understood. Therefore, we have set the following three aims in this proposal, combining a novel trophoblast modeling system, the molecular characterization of the placenta, and evaluate influence of mesenchymal stem/stromal cells (MSC) at the chorionic villi and elucidate the detailed

mechanism associated with this pathology. Aim 1 will identify the optimal stem cell-based method to study abnormal trophoblast differentiation in PE placenta. Aim 2 will focus on in-depth characterization of PE- MVM placentas with or without FVM, and bank and characterize the cellular phenotype of each MVM

subtypes of umbilical cord-derived MSCs. Aim 3 will evaluate the trophoblast-MSC crosstalk within the chorionic villi of PE placentas with different MVM-subtypes. The successful completion of this proposal will establish subtype-specific cell-based models of PE, providing effective tools for identifying diagnostic

biomarkers and therapeutic targets for each sutypes, leading us to the better pregnancy care for woman and babies.

All Grantees

University of California, San Diego

Advertisement
Apply for grants with GrantFunds
Advertisement
Browse Grants on GrantFunds
Interested in applying for this grant?

Complete our application form to express your interest and we'll guide you through the process.

Apply for This Grant